Cleared Traditional

K781516 - TEST SYSTEM TISSUE CELL CULTURE SLIDE (FDA 510(k) Clearance)

Class I Pathology device.

K781516 · Zeus Scientific, Inc. · Pathology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1978
Decision
27d
Days
Class 1
Risk

K781516 is an FDA 510(k) clearance for the TEST SYSTEM TISSUE CELL CULTURE SLIDE. Classified as Chamber, Slide Culture (product code KIY), Class I - General Controls.

Submitted by Zeus Scientific, Inc. (Mchenry, US). The FDA issued a Cleared decision on September 27, 1978 after a review of 27 days - a notably fast clearance cycle.

This device falls under the Pathology FDA review panel, regulated under 21 CFR 864.2240 - the FDA pathology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Zeus Scientific, Inc. devices

Submission Details

510(k) Number K781516 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 31, 1978
Decision Date September 27, 1978
Days to Decision 27 days
Submission Type Traditional
Review Panel Pathology (PA)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
50d faster than avg
Panel avg: 77d · This submission: 27d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code KIY Chamber, Slide Culture
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 864.2240
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.